赵红,谢雯

• 1:首都医科大学附属北京地坛医院肝病中心

摘要(Abstract)：

<正>胆汁淤积性肝病是各种原因引起的胆汁形成、分泌和(或)胆汁排泄异常引起的肝脏病变,随着更多研究结果的出现,国内外相关指南及共识也陆续发表,欧洲肝病学会(European Association for the Study of the Liver,EASL)和美国肝病学会(American Association for the Study of Liver Diseases,AASLD)分别于2009年及2010年发表了胆汁淤积性肝病和原发性硬化性胆管炎(PSC)、酒精性肝病的诊疗指南,2010年中华医学会修订

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 赵红,谢雯

参考文献(References)：

• [1]Heathcote EJ.Diagnosis and management of cholestatic liverdisease[J].Clin Gastroenterol Hepatol,2007,5(7):776-782.
• [2]European Association for the Study of the Liver.EASLClinical Practice Guidelines:management of cholestatic liverdiseases[J].J Hepatol,2009,51(2):237-267.
• [3]Chapman R,Fevery J,Kalloo A,et al.Diagnosis andmanagement of primary sclerosing cholangitis[J].Hepatology.2010,51(2):660-678.
• [4]Invernizzi P,Lleo A,Podda M.Interpreting serological testsin diagnosing autoimmune liver diseases[J].Semin Liver Dis,2007,27(2):161-172.
• [5]Lindor KD,Gershwin ME,Poupon R,Primary biliarycirrhosis[J].Hepatology.2009,50(1):291-308.
• [6]段维佳,张福奎,欧晓娟,等.原发性胆汁性肝硬化患者对熊去氧胆酸应答欠佳的影响因素[J].中华肝脏病杂志,2011,19(2):118-120.
• [7]Corpechot C,Abenavoli L,Rabahi N,et al.Biochemicalresponse to ursodeoxycholic acid and long-term prognosis inprimary biliary cirrhosis[J].Hepatology,2008,48(3):871-877.
• [8]Honda A,Ikegami T,Nakamuta M,et al.Anticholestatic effectsof bezafibrate in patients with primary biliary cirrhosis treatedwith ursodeoxycholic acid[J].Hepatology,2012,57(5)1931-1941.
• [9]Han XF,Wang QX,Liu Y,et al.Efficacy of fenofibrate inChinese patients with primary biliary cirrhosis partiallyresponding to ursodeoxycholic acid therapy[J].J Dig Dis.2012,13(4):219-224.
• [10]中华医学会妇产科学分会产科学组.妊娠期肝内胆汁淤积症诊疗指南(第1版)[J].中华妇产科杂志,2011,46(5):391-395.
• [11]Hay JE.Liver disease in pregnancy[J].Hepatology,2008,47(3):1067-1076.
• [12]吴晓宁,尤红,贾继东.2003-2007年国内药物性肝损伤临床特点文献综合分析[J].肝脏杂志,2008,13(6):463-466.
• [13]Ramachandran R,Kakar S.Histological patterns in drug-induced liver disease[J].J Clin Pathol,2009,62(6):481-492.
• [14]Chou JW,Yu CJ,Chuang PH,et al.Successful treatment offosinopril-induced severe cholestatic jaundice with plasmaexchange[J].Ann Pharmacother,2008,42(12):1887-1892.
• [15]O'Shea RS,Dasarathy S,McCullough AJ,et a1.Alcoholic liverdisease[J].Hepatology,2010,51:307-328.
• [16]中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):167-170.
• [17]Tilg H,Day CP.Management strategies in alcoholic liverdisease[J].Nat Clin Prsct Gastroenterol Hepaml,2007,4(1):24-34.
• [18]Barve A,Khan R,Marsano L,et al.Treatment of alcoholicliver disease[J].Ann Hepatol,2008,7(1):5-15.
• [19]Sykora P,Kharbanda KK,Crumm SE,et al.S-adenosyl-L-methionine co-administration prevents the ethanol-eliciteddissociation of hepatic mitochondrial ribosomes in male rats[J].Alcohol Clin Exp Res,2009,33(1):1-9.
• [20]Andringa KK,King AL,Eccleston HB,et al.Analysis ofthe liver mitochondrial proteome in response to ethanol andS-adenosylmethionine treatments:novel molecular targets ofdisease and hepatoprotection.Am J Physiol Gastrointest LiverPhysiol[J].2010,298(5):G732-745.
• [21]Mato JM,Cámara J,Fernández de Paz J,et al.S-adenosy-lmethionine in alcoholic liver cirrhosis:a randomized,placebo-controlled,double-blind,multicenter clinical trial[J].J Hepatol,1999,30(6):1081-1089.
• [22]马安林,郭新珍,刘霞等.双环醇与多烯磷脂酰胆碱治疗酒精性肝病的疗效比较[J].中华肝脏病杂志,2011,19(6):471-472.
• [23]王菲,王炳元.糖皮质激素在重症酒精性肝炎治疗中的应用[J].中华肝脏病杂志,2011,19(8):630-633.
• [24]Barve S,Joshi-Barve S,Song Z,et al.Interactions of cytokines,S-Adenosylmethionine,and S-Adenosylhomocysteine inalcohol-induced liver disease and immune suppression[J].JGastroenterol Hepatol,2006,Suppl 3:S38-42.